Skip to content

Berry Components and Blood Sugar & Fat Metabolism

Berry Components and Blood Sugar & Fat Metabolism

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03458858
Enrollment
36
Registered
2018-03-08
Start date
2018-02-13
Completion date
2018-06-28
Last updated
2019-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Brief summary

The primary objective of this study is to determine which components of berries improve glucose metabolism and increase fat oxidation in humans.

Detailed description

The aim of this study is to improve understanding of how diet can regulate glucose metabolism and fuel use. Previous human and animal studies have demonstrated that berries can improve gluco-regulation and increase fat oxidation. The aim of this study is to determine which component of berries is conveying this health benefit.

Interventions

OTHERLow Fiber Mixed Berry Juice

Anthocyanin Control

OTHERCarbohydrate Control Jello

Carbohydrate Control

OTHERFiber Enriched Jello

Fiber Control

OTHERMixed Berry Diet

Mixed Berry Treatment

Sponsors

USDA Beltsville Human Nutrition Research Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy non-smoker * able to understand consent

Exclusion criteria

* Body Mass Index less than 25 kg/m2 * pregnant, lactating, having given birth in the past year * allergy to berries * blood glucose greater than 125 mg/dL * history of bariatric surgery or nutrient malabsorption disease * diagnosis or treatment of cancer in past three years * type 2 diabetes requiring the use of diabetes pills, insulin, or non-insulin shots

Design outcomes

Primary

MeasureTime frameDescription
Glucose Metabolism Phase 4Day 71Subjects will undergo a meal-based glucose tolerance test; blood samples will be analyzed for glucose in mmol/L.
Glucose Metabolism Phase 1Day 8Subjects will undergo a meal-based glucose tolerance test; blood samples will be analyzed for glucose in mmol/L.
Glucose Metabolism Phase 2Day 29Subjects will undergo a meal-based glucose tolerance test; blood samples will be analyzed for glucose in mmol/L.
Glucose Metabolism Phase 3Day 50Subjects will undergo a meal-based glucose tolerance test; blood samples will be analyzed for glucose in mmol/L.

Secondary

MeasureTime frameDescription
Metabolic Fuel UseDay 7-8, 28-29, 49-50, 70-71Subjects will spend the night in an indirect calorimeter to measure their oxygen consumption and carbon dioxide evolution which will be used to calculate the dietary energy source being oxidized, expressed as respiratory quotient which is a unitless ratio of liters of O2 inhaled to liters of CO2 exhaled.
Insulin sensitivityDay 8, 29, 50, 71Subjects will undergo a meal-based glucose tolerance test; blood samples will be analyzed for insulin in units of microIU/mL.
Fat traffickingDay 8, 29, 50, 71Subjects will undergo a meal-based glucose tolerance test; blood samples will be analyzed for non-esterified fatty acids in mmol/L.
Peripheral mononuclear blood cells energeticsDay 8, 29, 50, 71Blood cells called peripheral mononuclear blood cells will be isolated and analyzed for mitochondrial function/oxygen consumption in nmol/ml.

Other

MeasureTime frameDescription
Metabolomics in bloodDay 8, 29, 50, 71Blood metabolomics profiling will be conducted by gas chromatography and liquid chromatography / time-of-flight mass spectrometry. Selected intensity of biochemicals in blood with mass ranging from 50 to 800 molecular weight will be assessed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026